Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer

Dan Liljenquist, Ge Bai, Gerard F. Anderson

Open source

DOI: 10.1056/nejmp1800861
Published: 2018-05-17
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmp1800861,
  title = {Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer},
  author = {Dan Liljenquist and Ge Bai and Gerard F. Anderson},
  year = {2018},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmp1800861},
  url = {https://doi.org/10.1056/nejmp1800861}
}

RIS

TY  - JOUR
TI  - Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer
AU  - Dan Liljenquist
AU  - Ge Bai
AU  - Gerard F. Anderson
PY  - 2018
JO  - New England Journal of Medicine
DO  - 10.1056/nejmp1800861
UR  - https://doi.org/10.1056/nejmp1800861
ER  -

APA

Liljenquist, D., Bai, G., & Anderson, G. F. (2018). Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer. New England Journal of Medicine. https://doi.org/10.1056/nejmp1800861

Source records

crossref · retrieved 2026-09-25T12:52:11.812Z